<DOC>
	<DOCNO>NCT00936104</DOCNO>
	<brief_summary>In current project aim study oncological process pancreatic cancer , perspective CSC-theory particular 'side population ' ( SP ) -approach . The SP seem enrich CSC n't priori exclude CSC-subpopulation . After isolation pancreatic cancer resection specimen , SP cell characterize gene-expression profiling base microarray analysis . We 'll identify marker pathway ( emphasis stem cell cancer -related one ) differentially express SP versus rest tumour cell ( 'main population ' MP ) . In order ass prognostic relevance SP , 'll study gene use high-throughput Nanostring technology 200 snap-frozen PDAC resection specimens patient prospective database . Finally , two monoclonal antibody ( mAB ) test novel therapeutic agent vivo ( mouse model ) , wherein choice mAB base prognostically relevant molecular target pathway obtain Nanostring result .</brief_summary>
	<brief_title>Side Population Pancreatic Ductal Adenocarcinoma ( PDAC )</brief_title>
	<detailed_description />
	<criteria>Resected pancreatic ductal adenocarcinoma ( PDAC ) Informed consent Age &lt; 18years Pregnancy Preoperative radiotherapy Preoperative chemotherapy IPMT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>pancreas</keyword>
	<keyword>cancer</keyword>
	<keyword>stem cell</keyword>
</DOC>